THE BUSINESS OF BIOTECH
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital even as he builds Tome Biosciences, where he serves as President & CEO.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
Brian Finrow
Jack Hoppin
Guillaume Pfefer
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, Ph.D.
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
FINANCE & CAPITAL MARKETS
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Clinical Leadership with Cue Biopharma's Anish Suri, Ph.D. & Dan Passeri, J.D.
DISCOVERY
Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D.
Tick-Derived Therapeutic Molecules With Akari Therapeutics' Rachelle Jacques
A Vaccine For Type 1 Diabetes With Diamyd Medical's Dr. Ulf Hannelius
REGULATORY
Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas
CMC Considerations For In-Human Studies With Drs. Edith Perez And Nathan Ihle
MANUFACTURING
Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.
In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
GSK's Michael Mehler On The Cell & Gene Talent Crunch
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
Filling A Vaccine Void With Cue Biopharma's Dan Passeri, J.D.
A Scale-Up Story With Solis BioDyne Drs. Kadri Artma And Angela Vaasa
CMC Developability Assessments For Rapid Ph.1 Entry With AltruBio's Gene Lee, Ph.D.
Acepodia's Approach To ACC & CAR Manufacturing Scalability